Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  1996-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1210/JCEM.81.11.8923861PMID 8923861
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metabolic effects of metformin in non-insulin-dependent diabetes mellitus.

  1995cited by this paper
• Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

  1995cited by this paper
• Metabolic effects of metformin addition to chronic glibenclamide treatment in type 2 diabetes.

  1994cited by this paper
• Acute Antihyperglycemic Mechanisms of Metformin in NIDDM: Evidence for Suppression of Lipid Oxidation and Hepatic Glucose Production

  1994cited by this paper
• Estimating gluconeogenic rates in NIDDM.

  1993cited by this paper
• The impact of metformin therapy on hepatic glucose production and skeletal muscle glycogen synthase activity in overweight type II diabetic patients.

  1993cited by this paper
• Metformin decreases gluconeogenesis by enhancing the pyruvate kinase flux in isolated rat hepatocytes.

  1993cited by this paper
• Metformin Improves Glucose, Lipid Metabolism, and Reduces Blood Pressure in Hypertensive, Obese Women

  1993cited by this paper
• Relative effects of calorie restriction and weight loss in noninsulin-dependent diabetes mellitus.

  1993cited by this paper
• Pathogenesis of NIDDM: A Balanced Overview

  1992cited by this paper
• Combined metformin-sulfonylurea treatment of patients with noninsulin-dependent diabetes in fair to poor glycemic control.

  1992cited by this paper
• Biguanides and NIDDM

  1992cited by this paper
• Lipolysis and gluconeogenesis from glycerol are increased in patients with noninsulin-dependent diabetes mellitus.

  1992cited by this paper
• Increased lipolysis and its consequences on gluconeogenesis in non-insulin-dependent diabetes mellitus.

  1992cited by this paper
• Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.

  1991cited by this paper
• Banting lecture 1990. Beta-cells in type II diabetes mellitus.

  1991cited by this paper
• Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy.

  1990cited by this paper
• Indirect calorimetry: methodological and interpretative problems.

  1990cited by this paper
• Glucose Toxicity

  1990cited by this paper
• Contribution of liver and skeletal muscle to alanine and lactate metabolism in humans.

  1990cited by this paper
• Mechanism of increased gluconeogenesis in noninsulin-dependent diabetes mellitus. Role of alterations in systemic, hepatic, and muscle lactate and alanine metabolism.

  1990cited by this paper
• Effect of Metformin on Carbohydrate and Lipoprotein Metabolism in NIDDM Patients

  1990cited by this paper
• Sequential changes in serum insulin concentration during development of non-insulin-dependent diabetes.

  1989cited by this paper
• Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake.

  1989cited by this paper
• Predominant Role of Gluconeogenesis in Increased Hepatic Glucose Production in NIDDM

  1989cited by this paper
• Metformin improves peripheral but not hepatic insulin action in obese patients with type II diabetes.

  1989cited by this paper
• Effects of hypocaloric diet and insulin therapy on metabolic control and mechanisms of hyperglycemia in obese non-insulin-dependent diabetic subjects.

  1988cited by this paper
• The disposal of an oral glucose load in patients with non-insulin-dependent diabetes.

  1988cited by this paper
• Inhibition of hepatic gluconeogenesis by metformin. Synergism with insulin.

  1988cited by this paper
• Effect of Metformin on Insulin-Stimulated Glucose Turnover and Insulin Binding to Receptors in Type II Diabetes

  1987cited by this paper
• Sample site selection for tracer studies applying a unidirectional circulatory approach.

  1987cited by this paper
• Mechanism of Metformin Action in Non-Insulin-Dependent Diabetes

  1987cited by this paper
• Higher liver copper concentration: a possible cause of poor hepatocytic regeneration and prognosis in Indian childhood cirrhosis (ICC)

  1985cited by this paper
• Determination of gluconeogenesis in vivo with 14C-labeled substrates.

  1985cited by this paper
• Cardiac output measured by impedance cardiography during maximal exercise tests.

  1985cited by this paper
• Glycemic effects of intensive caloric restriction and isocaloric refeeding in noninsulin-dependent diabetes mellitus.

  1985cited by this paper
• Lipid Research Clinics Program.

  1984cited by this paper
• A microfluorometric method for the determination of free fatty acids in plasma.

  1983cited by this paper
• Turnover and precursor-product relationships of nonlipid metabolites.

  1983cited by this paper
• Metformin: a review of its pharmacological properties and therapeutic use.

  1979cited by this paper
• Glucose clamp technique: a method for quantifying insulin secretion and resistance.

  1979cited by this paper
• Metformin: a review of its pharmacological properties and therapeutic use.

  1979cited by this paper
• Phenformin-associated lactic acidosis: pathogenesis and treatment.

  1977cited by this paper
• Phenformin-associated Metabolic Acidosis

  1976cited by this paper
• The Minnesota impedance cardiograph- theory and applications.

  1974cited by this paper
• Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

  1972cited by this paper
• Determination of Lactate Kinetics in the Human Analysis of Data From Single Injection vs. Continuous Infusion Methods

  1972cited by this paper
• Glucoregulatory responses in normal and diabetic dogs recorded by a new tracer method.

  1971cited by this paper
• Lactate Turnover and Gluconeogenesis in Normal and Obese Humans: Effect of Starvation

  1970cited by this paper
• ON THE HORMONAL REGULATION OF CARBOHYDRATE METABOLISM; STUDIES WITH C14 GLUCOSE.

  1963cited by this paper
• Measurement of size and turnover rate of body glucose pool by the isotope dilution method.

  1956cited by this paper

• Tissue Iron Predicts Metformin Responsiveness in a Mouse Model and in Humans with Type 2 Diabetes

  2026cites this paper
• Animal Model for Diabetes Co-Existing with Metabolic Syndrome

  2026cites this paper
• Metformin-mechanisms of its glycemia-reducing effect.

  2025cites this paper
• The Diabetes Prevention Program and Its Outcomes Study: NIDDK’s Journey Into the Prevention of Type 2 Diabetes and Its Public Health Impact

  2025cites this paper
• Patient-specific effects of metformin on the hepatic metabolism in adolescents with metabolic dysfunction-associated steatotic liver disease (MASLD)

  2025cites this paper
• A study on the ameliorative effects of goldenseal, goat's rue extracts, and berberine on glucose uptake compared to metformin in a cellular model

  2025cites this paper
• Repurposing Metformin: A New Frontier in Cancer Therapy

  2025cites this paper
• Metabolic and Vascular Insulin Resistance: Partners in the Pathogenesis of Cardiovascular Disease in Diabetes.

  2025cites this paper
• Low-dose metformin requires brain Rap1 for its antidiabetic action

  2025cites this paper
• Metformin efficacy and tolerance according to genetic polymorphisms of organic cation transporter 1 in Tunisian patients with type 2 diabetes

  2025cites this paper
• Ianus Bifrons: The Two Faces of Metformin

  2024cites this paper
• Managing insulin resistance: the forgotten pathophysiological component of type 2 diabetes.

  2024cites this paper
• Co-occurrence, toxicity, and biotransformation pathways of metformin and its intermediate product guanylurea: Current state and future prospects for enhanced biodegradation strategy.

  2024cites this paper
• Recent advances in understanding the mechanisms in skeletal muscle of interaction between exercise and frontline antihyperglycemic drugs

  2024cites this paper
• Metformin in gestational diabetes: physiological actions and clinical applications

  2024cites this paper
• Gluconeogenesis Flux in Metabolic Disease.

  2023cites this paper
• Beta‐cell function in type 2 diabetes (T2DM): Can it be preserved or enhanced?

  2023cites this paper
• Metformin: A Promising Alternative to Alleviate the Gastrointestinal Side Effects Associated

  2023cites this paper
• Metformin and exercise effects on postprandial insulin sensitivity and glucose kinetics in pre-and-diabetic adults.

  2023cites this paper
• AMPK inhibits liver gluconeogenesis: fact or fiction?

  2023cites this paper
• Metformin Impedes Oxidation of LDL In Vitro

  2023cites this paper
• Metformin regulates myoblast differentiation through an AMPK-dependent mechanism

  2023cites this paper
• Glycemia and Gluconeogenesis with Metformin and Liraglutide: A Randomized Trial in Youth-onset Type 2 Diabetes.

  2023cites this paper
• Why do some glucose‐lowering agents improve non‐alcoholic fatty liver disease whereas others do not? A narrative review in search of a unifying hypothesis

  2023cites this paper
• TorS ‐ Reframing a rational for type 2 diabetes treatment

  2023cites this paper
• Therapeutic application of natural compounds for skeletal muscle-associated metabolic disorders: A review on diabetes perspective.

  2023cites this paper
• A Comparative Study of Acidosis in Diabetic Advanced Chronic Kidney Disease Patients on and off Metformin

  2022cites this paper
• Let-7 underlies metformin-induced inhibition of hepatic glucose production

  2022cites this paper
• Metformin, phenformin, and galegine inhibit complex IV activity and reduce glycerol-derived gluconeogenesis

  2022cites this paper
• Will We Unlock the Benefit of Metformin for Patients with Lung Cancer? Lessons from Current Evidence and New Hypotheses

  2022cites this paper
• Metformin and bladder cancer: Drug repurposing as a potential tool for novel therapy: A review

  2022cites this paper
• Metformin improves glycemia independently of skeletal muscle AMPK via enhanced intestinal glucose clearance

  2022cites this paper
• Effect of fenofibrate in comparison to metformin on the biophysical and biochemical parameters in diabetic albino wistar rats

  2022cites this paper
• Metformin as a Potential Treatment Option for Endometriosis

  2022cites this paper
• Clinical presentations and prognosis of metformin-associated lactic acidosis patients in the intensive care unit: A 20-year survey

  2022cites this paper
• ArticleMetformin inhibits ROS production by human M

  2022cites this paper
• Metabolic Action of Metformin

  2022cites this paper
• Metformin Inhibits ROS Production by Human M2 Macrophages via the Activation of AMPK

  2022cites this paper
• Prediabetes: how pathophysiology drives potential intervention on a subclinical disease with feared clinical consequences.

  2021cites this paper
• Differential Loss of β-cell Function in Youth vs. Adults Following Treatment Withdrawal in the Restoring Insulin Secretion (RISE) Study.

  2021cites this paper
• Abnormal Glucose Tolerance in Prediabetes Patients with Acute Myocardial Infarction: Implications for Therapy

  2021cites this paper
• The Current and Potential Therapeutic Use of Metformin—The Good Old Drug

  2021cites this paper
• The effects of hydroxychloroquine on insulin sensitivity, insulin clearance and inflammation in insulin‐resistant adults: A randomized trial

  2021cites this paper
• Comparative Effects of Metformin and Dipeptidyl Peptidase-4 Inhibitors in Japanese Obese Patients with Type 2 Diabetes: A Claims Database Study

  2021cites this paper
• Insulin Secretion Predicts the Response to Antidiabetic Therapy in Patients With New Onset Diabetes.

  2021cites this paper
• Metformin improves glycemic variability in adults with type 1 diabetes mellitus: an open-label randomized control trial

  2021cites this paper
• Flavonoids Targeting Cancer Stem Cells for Augmenting Cancer Therapeutics

  2021cites this paper
• The Physiological Role of Irisin in the Regulation of Muscle Glucose Homeostasis

  2021cites this paper
• Mechanisms of Action of Metformin

  2021cites this paper
• Recommendations for Practical Use of Metformin, a Central Pharmacological Therapy in Type 2 Diabetes.

  2021cites this paper
• A Review on Metformin: Clinical Significance and Side Effects

  2021cites this paper
• Biguanides drugs: Past success stories and promising future for drug discovery.

  2021cites this paper
• Prevention of Hyperglycemia

  2021cites this paper
• Phase I study of metformin in combination with carboplatin/paclitaxel chemotherapy in patients with advanced epithelial ovarian cancer

  2020cites this paper
• Impact of Disturbed Glucose Homeostasis Regulated by AMPK in Endometrium on Embryo Implantation in Diabetes Mice

  2020cites this paper
• Metformin improves blood glucose by increasing incretins independent of changes in gluconeogenesis in youth with type 2 diabetes

  2020cites this paper
• Quantitative Assessment of Blood Lactate in Shock: Measure of Hypoxia or Beneficial Energy Source

  2020cites this paper
• Metformin as a potential therapeutic for neurological disease: mobilizing AMPK to repair the nervous system

  2020cites this paper
• Cohort Study of Antihyperglycemic Medication and Pancreatic Cancer Patients Survival

  2020cites this paper
• Pharmacological therapies to address obesity in type 1 diabetes.

  2020cites this paper
• Cellular and Molecular Mechanisms of Metformin Action

  2020cites this paper
• Effekte des Antidiabetikums Metformin und seines Transformationsprodukts Guanylharnstoff auf den Gesundheitszustand von Bachforellen (Salmo trutta f. fario) und Posthornschnecken (Planorbarius corneus)

  2020cites this paper
• Mortality and renal prognosis in isolated metformin‐associated lactic acidosis treated with continuous renal replacement therapy and citrate‐calcium‐anticoagulation

  2020cites this paper
• Association between metformin medication, genetic variation and prostate cancer risk

  2020cites this paper
• Association between metformin medication, genetic variation and prostate cancer risk

  2020cites this paper
• Recycling the Purpose of Old Drugs to Treat Ovarian Cancer

  2020cites this paper
• Synergistic effect of metformin and EGFR-TKI in the treatment of non-small cell lung cancer

  2020cites this paper
• Diabetes affects hepatic and renal glycoproteins: effect of Boswellia ovalifoliolata on glycoproteins proportions in diabetes induced hepatic and renal injury

  2020cites this paper
• Increase in Endogenous Glucose Production With SGLT2 Inhibition Is Unchanged by Renal Denervation and Correlates Strongly With the Increase in Urinary Glucose Excretion

  2020cites this paper
• Metformin Activity against Breast Cancer: Mechanistic Differences by Molecular Subtype and Metabolic Conditions

  2020cites this paper
• Exercise improves metformin 72-h glucose control by reducing the frequency of hyperglycemic peaks

  2020cites this paper
• Protective effects and mechanisms of Rehmannia glutinosa leaves total glycoside on early kidney injury in db/db mice.

  2020cites this paper
• Assessing Drug Safety Assessment: Metformin Associated Lactic Acidosis

  2020cites this paper
• Evidências do uso de frutas no tratamento complementar da Ansiedade e do Diabetes

  2020cites this paper
• Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus

  2019cites this paper
• From Pre-Diabetes to Diabetes: Diagnosis, Treatments and Translational Research

  2019cites this paper
• AMPK is associated with the beneficial effects of antidiabetic agents on cardiovascular diseases

  2019cites this paper
• Efficacy and Safety of Pioglitazone versus Glimepiride after Metformin and Alogliptin Combination Therapy: A Randomized, Open-Label, Multicenter, Parallel-Controlled Study

  2019cites this paper
• Mechanism of Action of Inhaled Insulin on Whole Body Glucose Metabolism in Subjects with Type 2 Diabetes Mellitus

  2019cites this paper
• Mulberry leaf active components alleviate type 2 diabetes and its liver and kidney injury in db/db mice through insulin receptor and TGF-β/Smads signaling pathway.

  2019cites this paper
• New anti-hyperglycaemic agents for type 2 diabetes and their effects on diabetic retinopathy

  2019cites this paper
• Metformin : a pharmacological approach integrating hyperinsulinemia and breast cancer at the molecular , cellular and clinical levels *

  2019cites this paper
• Insulin Resistance the Link between T2DM and CVD: Basic Mechanisms and Clinical Implications.

  2019cites this paper
• Short-term efficacy and safety of repaglinide versus glimepiride as augmentation of metformin in treating patients with type 2 diabetes mellitus

  2019cites this paper
• Metabolic Effects of Metformin in Humans.

  2019cites this paper
• HSOA Journal of Diabetes & Metabolic Disorders The Side Effects of Metformin - A Review

  2019cites this paper
• DMSO_A_198154 519..526

  2019cites this paper
• Novel halogenated sulfonamide biguanides with anti-coagulation properties.

  2019cites this paper
• Skeletal morbidity and its determinants in type 1 diabetes

  2019cites this paper
• Genetic deletion of a short fragment of glucokinase in rabbit by CRISPR/Cas9 leading to hyperglycemia and other typical features seen in MODY-2

  2019cites this paper
• Vitamin D as a modulating agent of metformin and insulin in patients with type 2 diabetes

  2019cites this paper
• Plasma cathepsin D activity is negatively associated with hepatic insulin sensitivity in overweight and obese humans

  2019cites this paper
• Metformin does not compromise energy status in human skeletal muscle at rest or during acute exercise: A randomised, crossover trial

  2019cites this paper
• Cardioprotection by Metformin: Beneficial Effects Beyond Glucose Reduction

  2018cites this paper
• The Influence of Metformin on Serum Carbohydrate Antigen 19-9 (CA 19-9) Levels in Type 2 Diabetes Mellitus Patients.

  2018cites this paper
• High amylose starch consumption induces obesity in Drosophila melanogaster and metformin partially prevents accumulation of storage lipids and shortens lifespan of the insects.

  2018cites this paper
• Severe lactic acidosis and hypoglycemia due to acute metformin intoxication in a dog.

  2018cites this paper
• Predictive Accuracy of Surrogate Indices for Hepatic and Skeletal Muscle Insulin Sensitivity.

  2018cites this paper
• The Therapeutic Potential of Metformin in Neurodegenerative Diseases

  2018cites this paper
• Exercise and insulin sensitivity: interaction with intrahepatic triglyceride and hepatokines

  2018cites this paper